Bellerophon Therapeutics (NASDAQ:BLPH) Share Price Passes Below 200-Day Moving Average – Here’s Why

Bellerophon Therapeutics, Inc. (NASDAQ:BLPH)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.04 and traded as low as $0.01. Bellerophon Therapeutics shares last traded at $0.01, with a volume of 7,027 shares.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on shares of Bellerophon Therapeutics in a report on Thursday. They set a “hold” rating for the company.

Bellerophon Therapeutics Trading Down 25.5 %

The company’s 50 day simple moving average is $0.03 and its 200 day simple moving average is $0.04. The stock has a market capitalization of $146,796.00, a PE ratio of -0.01 and a beta of 0.74.

Bellerophon Therapeutics Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Wednesday, December 18th. Stockholders of record on Friday, December 20th were given a $0.019 dividend. This represents a dividend yield of 117.8%. The ex-dividend date of this dividend was Thursday, December 19th.

Bellerophon Therapeutics Company Profile

Bellerophon Therapeutics, Inc, a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension.